gusperimus has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, F; Mae, T; Nemoto, K; Ogino, M; Sugawara, Y; Takeuchi, T | 1 |
| Nishikawa, K; Shibasaki, C; Takahashi, K; Takeuchi, T | 1 |
2 other study(ies) available for gusperimus and Adenocarcinoma
| Article | Year |
|---|---|
Myeloprotective activity of deoxyspergualin: influence on splenic colony-forming cell injury and antitumor activity of mitomycin C in mice.
Topics: Adenocarcinoma; Animals; Blood Cells; Bone Marrow; Bone Marrow Cells; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Interactions; Female; Guanidines; Immunosuppressive Agents; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred DBA; Mitomycin; Spleen; Stem Cells; Time Factors | 1992 |
Treatment schedule dependency of antitumor effect of deoxyspergualin.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Administration Schedule; Female; Guanidines; Infusions, Parenteral; Injections, Intraperitoneal; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Inbred Strains | 1991 |